Skip to main content

TB381

Product Details
WHO Product ID
TB381
Status
Prequalified
INN, dosage form and strength
Levofloxacin Tablet, Film-coated 250mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
Tuberculosis
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Film-coated
Applicant organization
Remington Pharmaceutical Industries (Pvt) Ltd
18 Km Multan Road
Lahore,
53800
Pakistan
Packaging details and storage conditions
Packaging Type
Blister, Alu-PVC
Configuration
10x1; 10x10
Shelf life (months)
36
Storage conditions
Do not store above 30°C, store in the original container, protect from light
API Manufacturing Site(s)
By Organization
By Active Ingredient
Shangyu Jingxin Pharmaceutical Co Ltd
Shangyu,
Zhejiang
312369
China
Levofloxacin
Zhejiang Langhua Pharmaceutical Co Ltd
No 7, Donghai 3rd Avenue, Zhejiang Provincial Chemical & Medical Materials Base Linhai Zone
Linhai City,
Zhejiang
317 016
China
Levofloxacin
FPP Manufacturing Site(s)
Remington Pharmaceutical Industries (Pvt) Ltd
18 Km Multan Road
Lahore,
53800
Pakistan
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorised for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , Part 4 , Part 5 , Part 6 , Part 7 , Part 8

.